Skip to main navigation
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
144
Filing Date
March 19, 2026
Document Date
March 19, 2026
Form Description
Filed by "insiders" prior intended sale of restricted stock.
Filing Group
Other
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2026 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter